Recall vaccination increases detectable B-cell reactivity in persons with multiple sclerosis treated with ocrelizumab
{{output}}
Background: Utility of repeated boosts of anti-SARS-CoV-2 vaccination in persons with MS (pwMS) treated with ocrelizumab is questioned. Objective: ... ...
